C. Bassi

Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes

G. Parmiani, M. Rodolfo, C. Salvi, 2005, Cancer Immunology, Immunotherapy.

Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: The pattern of in vitro reactivity predicts the in vivo effect on different tumours

G. Parmiani, M. Rodolfo, C. Salvi, 2005, Cancer Immunology, Immunotherapy.

Beyond neurotransmission: acetylcholine in immunity and inflammation

T. Mak, M. Saunders, R. Nechanitzky, 2019, Journal of internal medicine.

Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma

M. Colombo, A. Stoppacciaro, G. Parmiani, 1993, The Journal of experimental medicine.

Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T‐cell receptors

G. Parmiani, M. Rodolfo, C. Castelli, 1994, International journal of cancer.

Adoptive immunotherapeutic treatments with interleukin 2 and lymphocytes in a mouse colonic adenocarcinoma model.

G. Parmiani, M. Rodolfo, M. Sensi, 1990, Annali dell'Istituto superiore di sanita.